Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma.
dc.contributor.author | Sánchez-García, Silvia | |
dc.contributor.author | Ruiz Hornillos, Francisco Javier | |
dc.contributor.author | Bernaola, Marta | |
dc.contributor.author | Habernau-Menaf, Alicia | |
dc.contributor.author | Lasa, Eva María | |
dc.contributor.author | Contreras, Javier | |
dc.contributor.author | Candón-Morillo, Rocío | |
dc.contributor.author | Antón Rodríguez, Cristina | |
dc.contributor.author | Escudero, Carmelo | |
dc.date.accessioned | 2023-02-03T12:03:28Z | |
dc.date.available | 2023-02-03T12:03:28Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: The novel disease caused by the new coronavirus SARS-CoV-2 has caused an unprecedented global pandemic. Care providers of asthmatic children are increasingly con-cerned; as viral infections are one of the primary triggers of asthma flare-up. However, the effect of SARS-CoV-2 as well as the generated worldwide lockdown on asthmatic children is unknown. Objective: The aim of this study was to analyze the effects of pandemic SARS-CoV-2 in pediat-ric asthma control. Material and Methods: A retrospective, open, transversal study was performed at five ter-tiary hospitals. Recruited patients were aged <18 years and had physician-diagnosed asthma. Information regarding the 2019 and 2020 seasons were provided. Results: Data were collected from 107 children (age range: 3–18 years, mean age: 12 years). Well-controlled asthma was observed in 58 (54.2%) patients in 2020 versus 30 (28%) in 2019, and 15 (14%) patients had poorly controlled asthma in 2020 versus 28 (26.2%) in 2019. In 2020, a decrease in exacerbations caused by allergies to pollen, dust mites, molds, and through other causes not related to SARS-CoV-2 infection was observed. An increase in exacerbations was observed due to animal dander, stress, physical exercise, and SARSCoV- 2 infection | spa |
dc.description.extent | 362 KB | spa |
dc.identifier.doi | 10.15586/aei.v50i1.492 | spa |
dc.identifier.issn | 0301-0546 | spa |
dc.identifier.uri | https://hdl.handle.net/10641/3248 | |
dc.language.iso | eng | spa |
dc.publisher | Allergologia et immunopathologia | spa |
dc.relation.publisherversion | https://all-imm.com/index.php/aei/article/view/492 | spa |
dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | * |
dc.rights.accessRights | open access | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
dc.subject | Asthma control | spa |
dc.subject | Asthma severity | spa |
dc.subject | COVID-19 | spa |
dc.subject | Pediatric asthma | spa |
dc.subject | SARS-CoV-2 | spa |
dc.title | Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma. | spa |
dc.type | journal article | spa |
dc.type.hasVersion | AM | spa |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 72b2ac96-de6b-4634-aede-647e87a82b46 | |
relation.isAuthorOfPublication.latestForDiscovery | 72b2ac96-de6b-4634-aede-647e87a82b46 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- AEI_492-50-099.pdf
- Size:
- 361.54 KB
- Format:
- Adobe Portable Document Format
- Description: